Cite
MLA Citation
Subodh Verma et al.. “Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.” Lancet, vol. 10, no. 1, 2022, pp. 35–45. http://access.bl.uk/ark:/81055/vdc_100148052274.0x000025